2m 2m 2m 2m 2m 2m 2m
KINIKSA PHARMA (KNSA)
NASDAQ
$60.80-$0.14 (-0.23%)
Price as of Jul 14, 2026 4:28 AM EDT- $2.7BMarket Cap
- 111.60%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
KINIKSA PHARMA (KNSA)
$60.80-$0.14 (-0.23%)
KNSA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $60.94 | ||
Change | -$2.50 (-3.94%) | ||
Open | $63.43 | ||
High | $63.64 | ||
Low | $60.89 | ||
Previous Close | $63.44 | ||
Volume | 586,049 | ||
30-Day Average Volume | 1,081,087 | ||
1-Week Change | -2.92% | ||
1-Month Change | 17.44% | ||
1-Year Change | 111.60% | ||
3-Year Change | 338.10% | ||
5-Year Change | 340.96% | ||
Fundamentals | |||
Shares Outstanding | 42.0M | ||
Total Assets | $825.3M | ||
Market Cap | $2.7B | ||
Enterprise Value | $2.5B | ||
Period: QTR TTM FY | |||
Revenue | $214.3M | ||
Net Income | $22.6M | ||
Free Cash Flow | $50.0M | ||
EBIT | $32.7M | ||
EBITDA | $33.1M | ||
Net Working Capital | $437.6M | ||
EPS | $0.27 | ||
Enterprise Value/EBITDA | 75 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 4 | ||
P/E | 235 | ||
PEG | 4 | ||
Price/Free Cash Flow | 53 | ||
Price/Operating Cash Flow | 53 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue